Axogen (LTS:0HKD) Current Deferred Revenue : $0.0 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Axogen Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Axogen's current deferred revenue for the quarter that ended in Dec. 2023 was $0.0 Mil.

Axogen Current Deferred Revenue Historical Data

The historical data trend for Axogen's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Current Deferred Revenue Chart

Axogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Revenue

Get a 7-Day Free Trial

Axogen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Axogen Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Axogen's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Axogen (LTS:0HKD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (LTS:0HKD) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

AXGN:USA LT3:Germany

Address

13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615

Website

https://www.axogeninc.com

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Axogen (LTS:0HKD) Headlines

No Headlines